课题基金 / 基金详情

STRUCTURE/FUNCTION OF CB2 CANNABINOID RECEPTOR

STRUCTURE/FUNCTION OF CB2 CANNABINOID RECEPTOR
CB2 大麻素受体的结构/功能
批准号:
6522994
负责人:
ZHAO-HUI SONG
金额:
$10.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-30 至 2004-04-30

项目摘要

项目成果

ZHAO-HUI SONG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Abstract) The overall purpose of this research proposal is to identify the molecular basis underlying the functions of the CB2 cannabinoid receptor. One of the major problems for cannabinoids as therapeutic agents is their severe psychoactive side-effect. The recent cloning of CB2, a subtype of cannabinoid receptors, brought us new hope for a better medical use of cannabinoids. CB2 is distributed primarily in the peripheral tissues, whereas CB1 I distributed primary in the central nervous system. CB2 has only 44 percent amino acid identity with CB1. Recently several CB2-selective cannabinoid ligands have been discovered; the signal transduction pathway for CB2 is being identified; and the pharmacological properties of CB2 in a rat mast cell line, RBL-2H3 cells, have been shown to be different from those of the cloned human CB2. The hypotheses of this proposal include: 1. The ligand binding and signal transduction characteristics of CB2 are determined by its unique structural features. 2. The differences between RBL-2H3 cell cannabinoid receptors and human CB2 may be explained by either the structural differences between rat and human CB2, or the novel receptor subtypes that may exist in RBL-2H3 cells. The following specific aims will attempt to test these hypotheses: Specific Aim 1: To determine the amino acids of CB2 that are important for ligand binding. Specific Aim 2: To determine the amino acids of CB2 that are important for receptor activation. Specific Aim 3: To characterize cannabinoid receptor subtypes in a rat mast cell line (RBL-2H3). A combination of molecular cloning, mutagenesis, heterologous expression, and pharmacological assays will be utilized to test the hypotheses of this proposal. Molecular modeling studies will be performed collaboratively. These studies should help us to understand in more molecular detail the ligand binding and activation of cannabinoid receptor subtypes, particularly about CB2, which is a very important receptor for the immune-modulatory effects of marijuana and cannabinoids. Ultimately, this may facilitate the development of novel cannabinoid mimetics with improved therapeutic properties and minimized psychoactive side effects.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
CB2 cannabinoid receptors in trabecular meshwork cells mediate JWH015-induced enhancement of aqueous humor outflow facility.
小梁网细胞中的 CB2 大麻素受体介导 JWH015 诱导的房水流出设施增强。
DOI: 10.1167/iovs.04-0651
发表时间: 2005
期刊: Investigative ophthalmology & visual science
影响因子: 4.4
作者: [Zhong,Lichun, Geng,Lijun, Njie,Yafatou, Feng,Wenke, Song,Zhao-Hui]
通讯作者: Song,Zhao-Hui
Molecular and cellular changes induced by the activation of CB2 cannabinoid receptors in trabecular meshwork cells.
小梁网细胞中 CB2 大麻素受体激活引起的分子和细胞变化。
DOI: --
发表时间: 2007
期刊: Molecular vision
影响因子: 2.2
作者: [He,Fang, Song,Zhao-Hui]
通讯作者: Song,Zhao-Hui
The effects of charge-neutralizing mutation D6.30N on the functions of CB1 and CB2 cannabinoid receptors.
电荷中和突变 D6.30N 对 CB1 和 CB2 大麻素受体功能的影响。
DOI: 10.1016/j.febslet.2006.09.001
发表时间: 2006
期刊: FEBS letters
影响因子: 3.5
作者: [Nebane,NtsangM, Kellie,Brandon, Song,Zhao-Hui]
通讯作者: Song,Zhao-Hui
CB1 cannabinoid receptor-mediated changes of trabecular meshwork cellular properties.
CB1 大麻素受体介导的小梁网细胞特性变化。
DOI: --
发表时间: 2006
期刊: Molecular vision
影响因子: 2.2
作者: [Kumar,Akhilesh, Song,Zhao-Hui]
通讯作者: Song,Zhao-Hui
Endocannabinoid system as a therapeutic target for PVR
  • 批准号:
    10747004
  • 项目类别:
  • 资助金额:
    $44.53万
  • 财政年份:
    2023
  • 负责人:
    ZHAO-HUI SONG
  • 依托单位:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
  • 批准号:
    7655084
  • 项目类别:
  • 资助金额:
    $37.0万
  • 财政年份:
    2003
  • 负责人:
    ZHAO-HUI SONG
  • 依托单位:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
  • 批准号:
    6774098
  • 项目类别:
  • 资助金额:
    $29.4万
  • 财政年份:
    2003
  • 负责人:
    ZHAO-HUI SONG
  • 依托单位:
Cannabinoid Receptors and Novel Antiglaucoma Drugs
  • 批准号:
    7895529
  • 项目类别:
  • 资助金额:
    $37.0万
  • 财政年份:
    2003
  • 负责人:
    ZHAO-HUI SONG
  • 依托单位:
海外基金